The Real Chemistry Podcast artwork

Innovating Data Approaches for Clinical Trial Recruitment: Live from SXSW 2023

The Real Chemistry Podcast

English - March 30, 2023 08:00 - 47 minutes - ★★★★★ - 22 ratings
Business marketing communications leadership content creation engagement business entrpreneurialship Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Understanding Trends to Shape our Future Normal: Rohit Bhargava, Founder & Chief Trend Curator, Non-Obvious Company
Next Episode: A Day in the Life of a Biopharmaceutical Leader: Live from SXSW 2023

This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidates for a study. The panelists discuss the advantages and disadvantages of different data sources, such as the potential cost savings, access to a larger pool of potential participants and the ability to target specific populations. They also discuss potential ethical considerations, such as protecting participant privacy and ensuring that the data used is accurate and up-to-date.
Panelists

Bryan Hansen, Director of Data Science & Digital Health Neuroscience, Johnson & Johnson

Maimah Karmo, CEO & President, Tigerlily Foundation

Joan Severson, Chief Innovation Officer, Clinical Ink

Aaron Strout, Chief Marketing Officer, Real Chemistry (Host)

This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidates for a study. The panelists discuss the advantages and disadvantages of different data sources, such as the potential cost savings, access to a larger pool of potential participants and the ability to target specific populations. They also discuss potential ethical considerations, such as protecting participant privacy and ensuring that the data used is accurate and up-to-date.

Panelists


Bryan Hansen, Director of Data Science & Digital Health Neuroscience, Johnson & Johnson
Maimah Karmo, CEO & President, Tigerlily Foundation
Joan Severson, Chief Innovation Officer, Clinical Ink
Aaron Strout, Chief Marketing Officer, Real Chemistry (Host)